C. Guillen

No ORCID on file · 3 papers in corpus
other 2016
·doi:10.13140/rg.2.1.4231.8324
2010
·doi:10.1016/j.jmig.2010.08.667
other 1985
JAMA: The Journal of the American Medical Association ·doi:10.1001/jama.1985.03360060052015

To the Editor.— In a recent article Garewal et al1demonstrated that danazol, an attenuated androgen, given at a dose of 600 mg daily for eight to 14 weeks, is not useful in the treatment of factor VIII—deficient and factor IX—deficient hemo…